yes now the ongoing cash for ACR is going to be compromised. If they win the appeal it's different.
Looks like Eli Lilly doesn't want to pay for the FDA safety study.
Cash backing right now is ~20c
- Forums
- ASX - By Stock
- ACR
- Ann: Teva Launches Generic Version of Axiron in United States
Ann: Teva Launches Generic Version of Axiron in United States, page-11
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $1.898K | 35.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 23401 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 17258 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 23401 | 0.053 |
2 | 293669 | 0.052 |
2 | 21500 | 0.051 |
2 | 217490 | 0.050 |
2 | 262000 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 17258 | 1 |
0.059 | 18000 | 1 |
0.060 | 670 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 13.19pm 08/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |